Levi & Korsinsky, LLP announces that a TDOC class action lawsuit has been filed on behalf of investors who purchased  Teladoc Health, Inc.  (TDOC) securities between October 28, 2021, and April 27, 2022. For more on the TDOC Lawsuit please contact us today.

According to the Teladoc lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) increased competition, among other factors, was negatively impacting Teladoc’s BetterHelp and chronic care businesses; (ii) accordingly, the growth of those businesses was less sustainable than Defendants had led investors to believe; (iii) as a result, Teladoc’s revenue and adjusted EBITDA projections for FY 2022 were unrealistic; (iv) as a result of all the foregoing, Teladoc would be forced to recognize a significant non-cash goodwill impairment charge; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE TDOC CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Teladoc you have until August 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com